8-668626-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_207332.3(ERICH1):c.1230G>T(p.Met410Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0001 in 1,614,210 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_207332.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERICH1 | NM_207332.3 | c.1230G>T | p.Met410Ile | missense_variant | 5/6 | ENST00000262109.8 | NP_997215.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ERICH1 | ENST00000262109.8 | c.1230G>T | p.Met410Ile | missense_variant | 5/6 | 1 | NM_207332.3 | ENSP00000262109 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000578 AC: 88AN: 152210Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000147 AC: 37AN: 251466Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135910
GnomAD4 exome AF: 0.0000499 AC: 73AN: 1461882Hom.: 0 Cov.: 29 AF XY: 0.0000399 AC XY: 29AN XY: 727244
GnomAD4 genome AF: 0.000584 AC: 89AN: 152328Hom.: 0 Cov.: 33 AF XY: 0.000483 AC XY: 36AN XY: 74500
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.1230G>T (p.M410I) alteration is located in exon 5 (coding exon 5) of the ERICH1 gene. This alteration results from a G to T substitution at nucleotide position 1230, causing the methionine (M) at amino acid position 410 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at